Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06863311
What this trial is testing

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Karie Runcie 70
Not applicableNot Yet RecruitingNCT07480044
What this trial is testing

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Who this might be right for
Postoperative Delirium (POD)Prostate CancerKidney Tumor
Zhejiang University 220
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Not applicableWithdrawnNCT02061605
What this trial is testing

First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy

Who this might be right for
Benign Renal TumorsMalignant Renal Tumors
Laser Tissue Welding, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00112905
What this trial is testing

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Who this might be right for
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more
National Cancer Institute (NCI) 27
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Testing effectiveness (Phase 2)Study completedNCT00005056
What this trial is testing

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

Who this might be right for
Kidney Cancer
Cancer Research UK
Not applicableActive Not RecruitingNCT00760331
What this trial is testing

Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function

Who this might be right for
Hepatocyte Nuclear Factor 1-beta
University Hospital, Limoges 100
Testing effectiveness (Phase 2)Looking for participantsNCT06083922
What this trial is testing

CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT00862303
What this trial is testing

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fuzhou General Hospital 100
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Not applicableUnknownNCT00994188
What this trial is testing

A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members

Who this might be right for
Kidney NeoplasmKidney StoneUreteral Tumor+2 more
Tokushukai Medical Group 5
Not applicableStudy completedNCT04883827
What this trial is testing

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Vanderbilt-Ingram Cancer Center 180
Not applicableNot Yet RecruitingNCT06963970
What this trial is testing

Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans

Who this might be right for
DementiaCancerRenal Disease+1 more
VA Office of Research and Development 480
Large-scale testing (Phase 3)Looking for participantsNCT07489495
What this trial is testing

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 758
Large-scale testing (Phase 3)Study completedNCT02716792
What this trial is testing

Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

Who this might be right for
Pain; Bone Neoplasms; Neoplasm Metastasis
Hoffmann-La Roche 334
Testing effectiveness (Phase 2)Study completedNCT02002312
What this trial is testing

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Radboud University Medical Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05868265
What this trial is testing

Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 9
Early research (Phase 1)Looking for participantsNCT06553339
What this trial is testing

HS-10516 in Patients With VHL Syndrome Associated Tumors

Who this might be right for
Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT05108077
What this trial is testing

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Who this might be right for
Bladder CancerRenal Cancer
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 20
Next Page